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OBJECTIVES The purpose of this study was to evaluate the extent of atherosclerotic changes in
angiographically normal coronary arteries using intravascular ultrasound (IVUS) technique in
patients with coronary spastic angina.
BACKGROUND Nitric oxide activity was shown to be decreased in coronary arteries of patients with coronary
spastic angina (CSA). Decrease in nitric oxide causes arterial intimal hyperplasia or
thickening. However, it remains unclear whether intimal thickening is diffusely present in
coronary arteries of patients with CSA.
METHODS The IVUS study was performed in 26 patients with CSA and with normal coronary
angiograms and in 31 control subjects in whom age and gender was matched with those in
patients with CSA.
RESULTS Compared with control subjects, patients with CSA had significantly larger percent intima 1
media area (%I 1 M area), intima 1 media area and maximal intima 1 media thickness in
all of proximal, middle and distal segments (p , 0.01, respectively). Lumen area was
comparable between these groups. The presence of spasm was the most powerful independent
predictor of increase in percent intima 1 media area, in multiple-regression analysis with the
traditional risk factors as covariates.
CONCLUSIONS Intimal thickening existed entirely in a coronary artery in patients with CSA and with normal
angiograms, independently of other traditional risk factors. The diffuse intimal thickening in
the spasm coronary arteries is intimately related with coronary spasm. (J Am Coll Cardiol
2000;36:432–7) © 2000 by the American College of Cardiology
Coronary artery spasm has been shown to play an important
role in the pathogenesis of not only variant angina but also
ischemic heart disease in general, including other forms of
angina pectoris, acute myocardial infarction and sudden
death (1,2). We and others have demonstrated that the
entire coronary arteries, as well as the localized coronary
segments, are hyperreactive to constrictor effects to acetyl-
choline (ACh) in patients with coronary spastic angina
(CSA) and normal coronary angiograms (3,4). Further,
spasm frequently occurs in multiple coronary arteries in
patients with CSA (5). Recently, we have shown that the
endothelial function of not only coronary arteries but also
brachial arteries was impaired in patients with CSA (6).
Thus, the pathogenetic abnormalities responsible for coro-
nary spasm may not be confined to localized coronary
segments, but the abnormalities may exist in the entire
coronary and systemic arteries in patients with CSA.
Intravascular ultrasound (IVUS) imaging technique has
enabled visualization of the intraluminal and intramural
morphology of the coronary arteries (7). We previously
showed that nitric oxide (NO) activity was decreased or
deficient in the entire coronary arteries of patients with
CSA (8). A decrease in NO has been shown to cause arterial
intimal hyperplasia or thickening (9,10). We thus hypoth-
esized that the intimal thickening or atherosclerotic changes
might exist in the entire coronary arteries of patients with
CSA even in patients with angiographically normal coro-
nary arteries. To examine this hypothesis, we evaluated
morphological abnormalities of coronary arteries in 26
patients with CSA and with angiographically normal coro-
nary arteries using IVUS and compared the results with
those in 31 control subjects.
METHODS
Study subjects. The present study included 26 consecutive
patients with CSA and angiographically normal coronary
arteries (17 men and 9 women; mean age 62 years; range 49
to 72 years) in whom an episode of spontaneous angina
occurred at rest, associated with ischemic ST segment
changes on 12-leads electrocardiogram (ECG) or ambula-
tory ECG. All patients with CSA had angiographically
documented coronary spasm associated with ischemic ST-
segment changes (ST-segment elevation in 15 patients,
ST-segment depression in 11 patients) after intracoronary
injection of ACh, as reported previously (3,5). This study
also included 31 control subjects with atypical chest pain (14
men and 17 women; mean age 59 years; range 35 to 74
years) in whom age and gender was matched with those in
the patients with CSA. These control subjects underwent
diagnostic cardiac catheterization for evaluation of atypical
chest pain and did not show coronary spasm after the
intracoronary injection of ACh. Both groups of patients had
no organic stenosis angiographically. All antianginal drugs
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except for sublingual nitroglycerin were withdrawn at least 3
days before the study. No study patient had taken nitroglyc-
erin within 12 h of the study. No patient had previous
myocardial infarction, congestive heart failure or other
serious diseases. Characteristics of patients and control
subjects are shown in Table 1. Written, informed consent
was obtained from all patients before the study. The study
was in agreement with the guidelines approved by the ethics
committee at our institution.
Provocation test for coronary spasm. Coronary angiogra-
phy was performed by the standard Judkins technique with
contrast material in the morning when the patients were
fasting. The incremental doses of ACh (10, 50, 100 mg)
were injected into the coronary artery to provoke coronary
spasm as described previously (3,5). Coronary spasm was
defined as total or subtotal occlusion of the epicardial
coronary arteries associated with signs of myocardial isch-
emia such as chest pain and ischemic ST-segment changes.
Intravascular ultrasound imaging. After intracoronary in-
jection of 2 mg of isosorbide dinitrate, each segment was
examined using a mechanical IVUS system (7). In both
patients with CSA and control subjects, IVUS measurement
was performed at the proximal, middle and distal segments
of a coronary artery. The coronary artery, which showed the
strongest constriction to ACh, was selected for the IVUS
study among the three major coronary arteries in each
individual. Coronary angiographies were repeatedly per-
formed during the IVUS study to identify the exact location
of the ultrasound catheter in relation to the coronary
segments. The coronary angiograms were recorded in the
same videotapes that included the ultrasound images. The
segment for the IVUS measurement was selected as follows:
proximal segment was 10 mm, middle segment was 30 mm
and distal segment was 50 mm from the orifice of the each
coronary artery. The size of Judkins catheter was used to
calibrate the length of the coronary segment. The measure-
ment was performed at three points (the center of each
segment and points 5 mm proximal and distal to the center)
in each segment and the IVUS parameters were averaged
within each segment. The IVUS imaging system consisted
of an imaging catheter (Sonicath; Boston Scientific Corp.,
Massachusetts) and a SONOS intravascular system imaging
console (Hewlett-Packard). The imaging catheter had a
30-MHz single-piezoelectric crystal transducer mechani-
cally rotating at 1,800 rpm within a 3.5-F monorail cathe-
ters sheath. A 7F guiding catheter (Vector; Medtoronic,
Minneapolis, Minnesota) was used for insertion of the
intravascular ultrasound catheter. After additional adminis-
tration of heparin (2,000 U), a 0.014-in. angioplasty guide
wire was advanced through the ultrasound catheter and
fluoroscopically guided into the distal coronary artery. The
ultrasound imaging catheter was then advanced over the
guide wire into the coronary artery as distally as possible and
was then carefully pulled back to continuously image the
wall morphology. All images were recorded on super-VHS
videotape for subsequent data analysis.
Intravascular ultrasound analysis. Each videotape was
analyzed off-line by two independent experienced IVUS
analysts. With computer planimetry, the target sites were
assessed quantitatively using the following measurements.
The “total vessel area” represents the area within the border
between the hypo echoic media and the echo reflective
adventitia. The “lumen area” was planimetered along the
lumen-intimal border. Intima 1 media (I 1 M) area was
calculated as total vessel area minus lumen area and the
percent intima 1 media area (%I 1 M area) was calculated
as I 1 M area divided by total vessel area. The maximal I 1
M thickness was designated as the maximal diameter from
the lumen-intimal border to the echo reflective adventitia
border (Fig. 1). Analysis of intraobserver and interobserver
variability for measurement of total vessel cross-sectional
area showed high reproducibility (r 5 0.999, p , 0.001; and
r 5 0.995, p , 0.001, respectively).
Quantitative coronary angiography. A quantitative coro-
nary angiographic study was performed in the same manner
as described in our previous reports (3,8). The coronary
luminal diameter was measured quantitatively with the use
of a computer-assisted coronary angiographic analysis sys-
tem (Cardio 500; Kontron Instruments, Berlin, Germany)
in the proximal and distal coronary artery segments where
the IVUS study was performed. Coronary artery responses
to ACh (10 mg) were defined as percent diameter changes
Abbreviations and Acronyms
ACh 5 acetylcholine
CSA 5 coronary spastic angina
I 1 M 5 intima 1 media
IVUS 5 intravascular ultrasound
LAD 5 left anterior descending coronary
arteries
LCx 5 left circumflex coronary arteries
NO 5 nitric oxide
%I 1 M area 5 percent intima 1 media area
RCA 5 right coronary arteries
Table 1. Clinical Characteristics of Study Patients
Patients
With
CSA
(n 5 26)
Control
Subjects
(n 5 31)
Age (yr) 62 6 6 59 6 10
Women/men 9/17 17/14
BMI (kg/m2) 24 6 3 25 6 4
Total cholesterol (mg/dl) 198 6 38 199 6 28
HDL cholesterol (mg/dl) 51 6 12 53 6 18
Triglyceride (mg/dl) 165 6 119 159 6 98
Hypertension (%)† 4 (15) 9 (29)
Diabetes mellitus (%)‡ 7 (27) 5 (16)
Smoker (%)§ 16 (62)* 8 (26)
LVEF (%) 72 6 7 74 6 8
*p , 0.01 vs. control subjects. †Blood pressure $140/90 mm Hg or taking an
antihypertensive medication. ‡According to World Health Organization criteria or
taking an antidiabetic medication. §$20 cigarettes/day for $10 years. Data presented
are mean value 6 SD or number of patients (% of total). CSA 5 coronary spastic
angina; BMI 5 body mass index; LVEF 5 left ventricular ejection fraction.
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from baseline values (3,8). Any coronary arteries or seg-
ments that were not suitable for measurement because they
were hypoplastic, or because of interference by a superim-
posing branch or insufficient opacification with contrast
medium, especially in segment distal to a spasm site, were
excluded.
Statistical analysis. Data are expressed as mean (6SD)
unless otherwise indicated. For comparison of the IVUS
parameters between patients with CSA and control
subjects, two-way analysis of variance for repeated mea-
sures was used. When the group effect was significant,
differences between spasm and control groups at specific
segments were compared by Bonferroni’s test. Patients’
characteristics between the two groups were compared
using unpaired Student t test or chi-square tests. Corre-
lations between variables were tested with linear regres-
sion analysis. Multivariate analyses of the associations
were assessed using standard linear regression techniques,
with %I 1 M area (%) of the coronary arteries as the
dependent variable (11). Of the independent variables,
body mass index (kg/m2), total cholesterol (mg/dl) and
triglycerides (mg/dl) were treated as continuous variables.
Other independent variables were treated as categorical
variables, which were coded as the following dummy
variables: cigarette smoking ($20 cigarettes/day for $10
years), 0 for nonsmokers and 1 for smokers; hypertension
(blood pressure $140/90 mm Hg or taking an antihy-
pertensive medication), 0 for normotension and 1 for
hypertension; diabetes mellitus (according to the World
Health Organization criteria or taking an antidiabetic
medication) (12), 0 for absence and 1 for presence; and
spasm, 0 for absence and 1 for presence. A value of p ,
0.05 was considered significant.
RESULTS
Patients characteristics and provocation of coronary
spasm. There was no significant difference in the clinical
characteristics except for smoking history between the
patients with CSA and control subjects, as shown in Table
1. In patients with CSA, coronary spasm was demonstrated
in 36 coronary arteries, including 15 left anterior descending
coronary arteries (LAD), 5 left circumflex coronary arteries
(LCx) and 16 right coronary arteries (RCA) by the intra-
coronary injection of ACh. Spasm occurred in one coronary
artery in 13 patients, in two coronary arteries in 10 patients,
and in three coronary arteries in 1 patient (i.e., multivessel
spasm in 11 patients).
Comparison of IVUS measurements (Table 2). Intravas-
cular ultrasound was performed in only one spasm coronary
artery per each of 26 patients with CSA (9 left LAD, 3 LCx
and 14 RCA). In control subjects, IVUS was performed at
31 coronary arteries (24 LAD, 4 LCx and 3 RCA). Percent
intima 1 media area was significantly greater in all of
proximal, middle and distal segments in spasm coronary
arteries as compared with the respective segments in control
coronary arteries. Maximal I 1 M thickness and I 1 M area
were greater in all segments in spasm coronary arteries as
compared with the respective segments in control coronary
arteries. Total vessel area in spasm coronary arteries was also
greater than that in control group (Fig. 2). Lumen area was
comparable between patients with CSA and control sub-
jects. Coronary artery spasm and coronary constriction did
not occur during the IVUS study, assessed by coronary
angiograms taken simultaneously during the IVUS study.
Multiple regression analysis of %I 1 M area (Table 3).
Because the traditional risk factors are known to be associ-
ated with coronary atherosclerosis (13), the influence of
these factors on the association of spasm with the intimal
thickening was examined in multiple linear regression anal-
yses. Coronary spasm and the traditional risk factors includ-
ing hypertension, diabetes mellitus, smoking, serum levels
of total cholesterol and triglyceride and body mass index
were included as covariates in the multivariate analysis. In
multiple-regression analysis, the presence of spasm and
history of smoking were independently associated with the
%I 1 M area, as shown in Table 3. The presence of spasm
was the most powerful independent predictor of the increase
in %I 1 M area. When the coronary arteries analyzed
(LAD and RCA) were added with the covariates, spasm
and smoking remained a significant and independent factor
(spasm: regression coefficients 5 13.63, standardized re-
gression coefficients 5 0.58, standard error 5 2.61, p ,
0.001; smoking: regression coefficients 5 8.67, standardized
regression coefficients 5 0.37, standard error 5 2.75, p ,
0.01), but the coronary arteries did not have a significant
association with the %I 1 M area (LAD: regression
coefficients 5 5.79, standardized regression coefficients 5
0.25, standard error 5 3.65, p 5 0.12; RCA: regression
Figure 1. Schematic representation of intravascular ultrasound analyses at
coronary cross-sectional image.
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coefficients 5 1.56, standardized regression coefficients 5
0.06, standard error 5 4.02, p 5 0.70).
Correlation of intimal thickening with vasomotor re-
sponse to ACh. It was further evaluated whether extent of
intimal thickening may be related with hyperreactivity of
coronary vasomotor response to ACh. The %I 1 M area
was significantly and positively correlated with the degree of
constrictive response to ACh in coronary arteries (Fig. 3).
DISCUSSION
Diffuse intimal thickening. The present study showed
that the I 1 M area was thickened diffusely and entirely in
a coronary artery in patients with CSA. Although the
boundary of the intima and media cannot be distinguished
accurately in atherosclerotic lesion by the IVUS technique,
morphological change of media dose not occur except for
very advanced atherosclerotic stages (14), and our histolog-
ical study previously demonstrated that spasm coronary
arteries had intimal hyperplasia but that they had no
significant change of media (15). Accordingly, increase in
I 1 M area and %I 1 M area might reflect an intimal
thickening of coronary arteries in this study.
It was previously thought that coronary spasm was prone
to occur at the sites of organic stenosis (16,17). A previous
IVUS study also showed that intimal thickening was locally
present at the spasm sites of coronary arteries in patients
with CSA (18). However, hyperreactivity to various con-
strictors is not localized but is observed at the entire
segments of coronary arteries, especially in angiographically
normal coronary arteries in patients with CSA (3,19). We
have shown that spasm frequently occurs in multiple coro-
nary arteries in patients with CSA and that spasm is not
confined to the sites of fixed coronary stenosis but occurs
diffusely at angiographically normal segments (3,5,20). The
present study further showed that extent of the ultrasound
Figure 2. Representative images of the left coronary angiogram and the
intravascular ultrasound (IVUS) in a patient with coronary spastic angina.
(Top right) Intracoronary injection of acetylcholine (100 mg) induced
subtotal occlusion of the left anterior descending and left circumflex
coronary artery. (Bottom left) After administration of isosorbide dinitrate,
the coronary arteries were dilated and no fixed stenosis was noted.
Intravascular ultrasound image exhibited a thickened I 1 M area and this
lesion existed eccentrically (the position of the ultrasound transducer is
noted by the black arrow on the angiogram after administration of
isosorbide dinitrate).
Table 2. Quantitative Data of IVUS
Spasm
(n 5 26)
Control
(n 5 31)
Two-way ANOVA
Segment Group Interaction
Intima 1 media area (mm2) (P) 6.8 6 2.7 4.1 6 2.5*
(M) 6.0 6 3.3 2.5 6 1.5* p , 0.001 p , 0.001 p 5 0.54
(D) 4.5 6 4.3 1.9 6 2.0*
All 5.8 6 3.5 2.9 6 2.2*
Total vessel area (mm2) (P) 19.9 6 4.1 18.5 6 4.7
(M) 18.0 6 4.8 13.0 6 3.8* p , 0.001 p , 0.001 p 5 0.01
(D) 16.5 6 7.0 10.7 6 4.9*
All 18.2 6 5.5 14.2 6 5.5*
%intima 1 media area (%) (P) 34.7 6 13.2 22.5 6 12.1*
(M) 33.0 6 14.8 18.8 6 7.4* p , 0.001 p , 0.001 p 5 0.35
(D) 25.2 6 17.4 16.6 6 8.4*
All 31.2 6 15.5 19.4 6 9.7*
Maximal intima 1 media (P) 0.75 6 0.35 0.49 6 0.37*
thickness (mm) (M) 0.70 6 0.39 0.32 6 0.2* p , 0.001 p , 0.001 p 5 0.32
(D) 0.49 6 0.49 0.25 6 0.18*
All 0.65 6 0.42 0.36 6 0.28*
Lumen area (mm2) (P) 13.1 6 3.9 14.4 6 4.3
(M) 12.0 6 3.8 10.5 6 3.0 p , 0.001 NS p , 0.01
(D) 11.9 6 5.6 8.8 6 3.4
All 12.4 6 4.4 11.3 6 4.3
Data presented are mean value 6 SD.
p values are tabulated for segment, group (spasm and control) effects and interaction by two-way repeated-measures ANOVA.
When the group effect is significant, differences between groups at each segment are compared by Bonferroni’s test (*p , 0.01 vs. respective segments in spasm group).
(P) 5 proximal segment; (M) 5 middle segment; (D) 5 distal segment; %intima 1 media 5 Intima 1 Media areaz100/total vessel area.
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intimal thickening was positively correlated with the degree
of constrictive response to ACh. Thus, intimal thickening
and hyperconstrictive response exist concomitantly and
entirely in a coronary artery with normal angiogram in
patients with CSA. Taken together, coronary spasm is not
a localized but a generalized disorder that involves the entire
coronary arteries and is associated with intimal thickening.
Risk factors and intimal thickening. It is also to be noted
that atherosclerotic risk factors such as hypercholesterolemia
and diabetes are not associated with intimal thickening in the
present study. It is known that the traditional coronary risk
factors are related to the extent of ultrasound atherosclerotic
changes even in angiographically normal coronary arteries
(21,22). However, the present study demonstrated that the
extent of %I 1 M area was most strongly associated with
spasm independently of other traditional risk factors in the
patients with CSA and normal coronary angiograms. Thus,
the presence of spasm may have causal relationship with
intimal thickening in patients with CSA and normal coronary
angiogram. Our and other histological studies previously
showed that spasm coronary arteries had an intimal hyperplasia
with few lipid-rich lesions, which was a distinct histological
feature in spasm coronary arteries as compared with coronary
arteries with atheromatous fixed stenosis (14,23). On the basis
of the histological classification of human atherosclerotic le-
sions (14), this histoloical feature of spasm coronary arteries is
likely to correspond to adaptive intimal thickening, which is
elicited by low flow forces in the eccentric locations of coronary
arteries. Hypercholesterolemia is a strong risk factor for ather-
omatous plaques enriched with foam cells (24). Also, smoking
might be a risk factor for lipid-rich lesions in concert with
hyperlipidemia, but smoking alone is thought to have less effect
on the development of lipid-rich lesions (25). It is known that
only smoking among traditional risk factors is strongly associ-
ated with patients with CSA (26–28). Thus, the intimate
association of smoking but not hyperlipidemia with patients
with CSA may be related to the intimal hyperplasia with few
lipid-rich lesions in spasm coronary arteries.
Decrease in NO activity and intimal thickening. The
present study demonstrated that the total vessel area was
greater in patients with CSA than control subjects, whereas the
lumen area was comparable between both groups. This is
compatible with the Glagov’s concept that coronary arteries
enlarge by the increase in shear stress in relation to plaque
development (29,30). Shear stress has an important role in the
arterial remodeling and regulation of the arterial tone through
various endothelium-derived factors such as NO released in
response to shear stress (31,32). Nitric oxide, a known endog-
enous vasodilator, suppresses proliferation and migration of
arterial smooth muscle cells (33,34). In fact, atherosclerotic
lesions are prone to occur at coronary arterial bends and branch
points where endothelium-derived NO may be decreased
because of low and/or fluctuating shear stresses (35,36). Fur-
ther, inhibitors of NO synthase or targeted disruption of
endothelial NO synthase gene caused the arterial intimal
thickening in experimental animals (9,10). We recently found
that endothelial NO was deficient or decreased in spasm
coronary arteries in patients with CSA (8,37). The decreased
NO activity in spasm coronary arteries may be related to high
frequency of smoking and mutations of endothelial NO
synthase gene in these patients (26,27,38). The present study
showed that intimal thickening had a close and positive
relationship with the coronary constrictor response to acetyl-
choline, which was known to depend on endothelial NO
activity, as shown in our and other previous reports (38,39).
Thus, the decrease in endothelial NO activity may be one of
the underlying mechanisms for the intimal thickening in spasm
Figure 3. Correlation between percent I 1 M area versus percent changes
from baseline in coronary lumen diameters in response to acetylcholine
(10 mg).
Table 3. Multiple Regression Analysis of %Intima 1 Media Area
Regression
Coefficients
Standard
Error
Standardized
Regression
Coefficients T Value 95% C.I. p Value
Spasm 12.711 2.443 0.545 5.204 7.89–17.62 , 0.001
Smoking 7.183 2.650 0.305 2.711 1.86–12.51 , 0.01
Hypertension 5.491 2.821 0.200 1.947 20.18–11.16 0.06
Diabetes mellitus 4.175 2.852 0.148 1.464 21.56–9.91 0.15
Body mass index 0.268 0.326 0.083 0.822 20.39–0.92 0.41
Triglyceride 20.007 0.012 20.061 20.566 20.03–0.02 0.57
Total cholesterol 0.016 0.038 0.044 0.418 20.06–0.09 0.68
Constant 7.480 10.053 0.744 212.73–27.69 0.46
C.I. 5 confidence interval.
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coronary arteries. Decrease in endothelial NO activity also
results in the increase in endothelial endothelin production
(40), which may also participate in the intimal thickening
and the hyperconstrictive responses in spasm coronary
arteries. And the endothelial injury caused by coronary
spasm could, in turn, induce coronary spasm. This positive
feedback mechanism may amplify this sequence of events,
thereby leading to further progression of the intimal hyper-
plasia and the arterial remodeling.
Conclusions. Intima is diffusely thickened in the spasm
coronary arteries even in patients with normal angiograms, and
this may possibly reflect the deficiency of NO activity that is
intimately related with coronary spasm in these patients.
Reprint requests and correspondence: Dr. Hirofumi Yasue,
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